Navigation Links
Robert Allard, Law Firm of Corsiglia, McMahon & Allard Named 2009 Trial Lawyer of the Year
Date:12/9/2009

Santa Clara County Trial Lawyers Association names Robert Allard, law firm of Corsiglia, McMahon & Allard, as its 2009 Trial Lawyer of the Year for the second time in three years.

(PRWEB) December 9, 2009 -- For the second time in three years Robert Allard of the law firm Corsiglia, McMahon & Allard has been named Trial Lawyer of the Year by the Santa Clara County Trial Lawyers Association.

Allard has developed a reputation for taking tough cases where insurance companies offer little or no money to an injured victim and for providing aggressive representation which generates just compensation for his clients.

In a case earlier this year, Egbert vs. Nor Cal ReLiEF, Allard secured a $2.056 million arbitration award for a public school behavioral specialist who was seriously injured in a head-on car crash while traveling on a school field trip. Despite a clear case of liability, horrific injuries and hundreds of thousands of dollars in medical bills and lost wages, the school district's relief fund (Nor Cal ReLiEF) never offered a penny in settlement and resorted to fighting the victim every step of the way.

In another case, a nursing assistant suffered severe neck problems that required surgery after she was rear-ended at ten miles an hour. Allard took over the case from another law firm and secured $1.25 million from Allstate. For years Allstate claimed that a low speed accident could not cause such medical problems. Upon taking over the case Allard successfully developed the proof that his client's pre-existing conditions triggered the neck injuries and subsequent surgical procedures.

“Robert Allard tirelessly works for justice on behalf of his clients. He has a commitment to holding those that injure hardworking Americans personally responsible for their actions,” said Mark Sigala, President, Santa Clara County Trial Lawyers Associ
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Raleigh Dentist Dr. Robert Williamson to Educate Patients About Sedation Dentistry
2. Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the New Senate Health Reform Bill
3. Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge
4. WaferGen Adds Robert Coradini, Former President of J&J New Ventures, to Board of Directors
5. Robert Wood Johnson Foundation, The Pew Charitable Trusts Launch National Initiative to Advance Policies That Promote Health
6. Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on The Senate Finance Committees Health Reform Plan
7. Oceanview Publishing Announces the Forthcoming Release of What's Next…For You? by Robert and Patricia Gussin
8. R. Kerry Clark and Robert J. Palmisano Join Bausch & Lomb Board of Directors
9. Public Option Still Viable As House Set to Pass It -- Not Fading, Says Robert Weiner, Former House Aging Committee Director
10. Robert Fanning Named to PerfectServe Advisory Board
11. The Aftermath: Robert Carson Krause Writes About his Struggle with PTSD and his Belief that War Is a Senseless Exercise in Futility
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Robert Allard, Law Firm of Corsiglia, McMahon & Allard Named 2009 Trial Lawyer of the Year
(Date:6/19/2013)... 19, 2013 Brightree LLC , ... software solutions for the post-acute care industry, has been ranked ... the Healthcare Informatics 100 (HCI 100) list. This ... the U.S. in terms of revenue during the last fiscal ... rate of 85% annually, and the company has built its ...
(Date:6/19/2013)... AZ (PRWEB) June 19, 2013 Guests at ... healthy, wealthy and wise even if they don’t go to ... does require some early thought. , Crafty ... when they take advantage of the pet-friendly Scottsdale Paradise Valley ... Package . With at least 14 days advance notice, guests ...
(Date:6/19/2013)... Boca Raton, FL (PRWEB) June 19, 2013 ... spoke about the positive changes and growth that has occurred ... his nationwide travel club. , Shuman said, "Travel Services has ... program to heights beyond belief. Membership is up, even ... agents to meet the demands of members." , Having been ...
(Date:6/19/2013)... Amerinet, Inc, a leading national ... to help Pacific Medical Centers implement a comprehensive ... than 17 percent over the organization’s previous clinical ... economies of scale and process standardization are two ... multi-site providers,” said Shawn Padilla, director of supply ...
(Date:6/19/2013)... lateral sclerosis (ALS), also known as Lou Gehrig,s Disease, ... classified into four distinct stages, report pathologists with the ... in the Annals of Neurology . This post-mortem ... for the first time, how the fatal degenerative disease ... nervous system to other regions of brain and spinal ...
Breaking Medicine News(10 mins):Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2
... is a Wholly Owned Subsidiary of Shamir, KIBBUTZ ... SHMR ) ("Shamir"), a leading provider of innovative,products ... it has,signed an agreement yesterday, June 30, 2008, pursuant ... ("Altra") from its minority,shareholder. Prior to this transaction, Shamir ...
... Conn., July 1 UTC Power, a United,Technologies Corp. ... supply St.,Helena Hospital in California,s Napa Valley with its ... will be in full,production in the summer of 2009., ... hospital and,part of Adventist Health, a not-for-profit health care ...
... July 1 Opus Healthcare Solutions, Inc.,a ... has named Ray,Bechtold, CPA, as controller. Based ... responsible for overseeing all accounting and financial,administrative ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO ), Bechtold joined ...
... RGEN ) announced today that Dr. Alfred L. ... Dr. Goldberg is currently a Professor of,Cell Biology at ... in,particular for elucidating the structure and function of the ... destroyed in,cells. In addition, he has made major contributions ...
... pain. This was the result of the analysis ... her colleagues and published in the current edition ... Int, 2008; 105[24]: 441-8). , http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=60552 ... more than 8000 private persons in the course ...
... staying asleep increase as women go through menopause ... Waking up earlier than planned also increases through ... The study is published in the July 1 ... "Sleep difficulties, especially problems staying asleep, are relatively ...
Cached Medicine News:Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 2Health News:Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH 3Health News:St. Helena's Hospital Orders New Model 400kW Fuel Cell From UTC Power 2Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 3Health News:Sleep problems associated with menopause vary among ethnic groups 2
(Date:6/19/2013)... June 19, 2013   Voices Against Brain Cancer ... cure for brain cancer, today announced that it has ... support the clinical investigation of Toca 511 & Toca ... glioma brain cancer (Grade 3 or Grade 4).  Tocagen ... for advanced cancer, with an initial focus on brain ...
(Date:6/19/2013)...   Nektar Therapeutics (Nasdaq: NKTR ) ... (HAL) study for NKTR-181, a first-in-class, opioid analgesic ... This slow rate of entry is designed to reduce the ... to current opioid analgesics. 1 In the study data ... placebo in "drug liking" and "feeling high" scores and had ...
(Date:6/19/2013)... ZIONA, Israel , June 19, ... that results from a phase I study in volunteers, ... advanced Parkinson,s patients, of ND0612, were presented at the ... ND0612 is a proprietary levodopa/carbidopa liquid drug formula under ... patch that would maintain constant levodopa plasma concentrations. ...
Breaking Medicine Technology:Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6
... PLAINS, N.Y., AUG. 2 Two major studies,published today ... doctors,better identify pregnant women at risk for preterm delivery ... Foundation said today. In one large multi-center trial ... (most of whom had no prior history of preterm ...
... - Access to Large Population of Glioblastoma Patients Expected ... Phase ll Study of Promising New Approach -, ... PPHM ), a clinical stage biopharmaceutical,company developing targeted monoclonal ... infection, today announced that the first,patient has been administered ...
Cached Medicine Technology:Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 2Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 3Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India 4
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
... designed for rigid skeletal fixation, ... freedom in positioning the fixation ... fixation is designed for the ... positions. Craniotomies can be performed ...
Medicine Products: